GRK2 and B-cell chronic lymphocytic leukemia: In addition to this newly described role in MALT1-dependent lymphoma, protein-protein interactions involving GRK2 have also been implicated as influencing the pathogenesis of the related B-cell malignancy, chronic lymphocytic leukemia (CLL).